{
    "clinical_study": {
        "@rank": "154917", 
        "brief_summary": {
            "textblock": "To test the safety and immunogenicity of rgp 120/HIV-1IIIB vaccine in HIV-1 seropositive\n      adult patients."
        }, 
        "brief_title": "A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers", 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have the following:\n\n          -  Stage 1 or 2 Walter Reed clinical staging of HIV infected individuals.\n\n          -  The ability to understand and sign a written informed consent form, which must be\n             obtained prior to study entry.\n\n          -  Be available for 24 weeks so that follow up may be completed.\n\n          -  Qualify for care as Department of Defense health care beneficiary.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following conditions or symptoms are excluded:\n\n          -  Prior history of clinically significant cardiac, pulmonary, hepatic, renal,\n             neurologic or autoimmune disease, other than HIV-1 infection, and in less than\n             average general health as determined by a medical history, physical examination, and\n             the required laboratory test results.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Corticosteroids or other known immunosuppressive drugs.\n\n          -  Any experimental agents.\n\n        Patients with the following are excluded:\n\n          -  Prior history of clinically significant cardiac, pulmonary, hepatic, renal,\n             neurologic or autoimmune disease, other than HIV-1 infection, and in less than\n             average general health as determined by a medical history, physical examination, and\n             the required laboratory test results.\n\n        Prior Medication:\n\n        Excluded within 30 days of study entry:\n\n          -  Zidovudine or other anti-retroviral agents."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001992", 
            "org_study_id": "075A", 
            "secondary_id": "V0200g"
        }, 
        "intervention": {
            "intervention_name": "rgp120/HIV-1IIIB", 
            "intervention_type": "Biological"
        }, 
        "keyword": [
            "Vaccines, Synthetic", 
            "Drug Evaluation", 
            "Acquired Immunodeficiency Syndrome", 
            "AIDS Vaccines"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rockville", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20850"
                }, 
                "name": "Walter Reed Army Institute of Research"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001992"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Genentech", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 1992"
    }, 
    "geocoordinates": {
        "Walter Reed Army Institute of Research": "39.084 -77.153"
    }
}